-+ 0.00%
-+ 0.00%
-+ 0.00%
NFL Biosciences to Attend BIO-Europe for Drug Partnership Talks
Share
Listen to the news
NFL Biosciences to Attend BIO-Europe for Drug Partnership Talks
  • NFL Biosciences will attend BIO-Europe in Cologne, Germany, November 9–11, 2026, to advance pharmaceutical partnership talks.
  • Discussions target funding for NFL-101's Phase 3 development and Part B of NFL-102's Phase 2 TONIC trial.
  • The goal is a single pharmaceutical partner for both drug candidates.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NFL Biosciences SA published the original content used to generate this news brief on October 30, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending